Non-obstructive azoospermia accounts for a considerable proportion of male factor infertility. Current therapies for treatment of this kind of infertility include procedures such as intracytoplasmic sperm injection (ICSI), round spermatid injection (ROSI), round spermatid nucleus injection (ROSNI) and elongated spermatid injection (ELSI). All involve injection of haploid germ cells retrieved from testicular biopsies into recipient oocytes. We have investigated a mouse model of azoospermia for quality of haploid germ cell genomes, based on 4,6-diamidino-2-phenylindole (DAPI)/TdT-mediated dUTP nick-end labelling (TUNEL) labelling. The mouse model, a targeted mutation in the protein phosphatase 1cg gene, results in severe depletion of haploid germ cells from the round spermatid stage on. Mice homozygous for the mutation are completely infertile, and produce only the occasional spermatozoon. Spermatozoa and round spermatids retrieved from either the epididymides or the testes of mutant mice displayed very high rates of DNA fragmentation. In contrast, similar cells retrieved from heterozygous or wild-type littermates displayed low levels of DNA fragmentation. In some cases, the high rates of DNA fragmentation in mutant cells could be lowered by inclusion of antioxidants in the retrieval media. High rates of DNA fragmentation were also observed in round spermatids retrieved from testicular biospies of human patients with non-obstructive azoospermia. These results suggest that one of the features of the pathology associated with azoospermia is fragmented DNA in haploid germ cells. This raises questions about the suitability of using these cells for fertility treatment.
Introduction
Intracytoplasmic sperm injection (ICSI) has achieved tremendous success in the treatment of male factor infertility over the past several years. However, for azoospermic men, results were less favourable, due to the absence of mature spermatozoa in the ejaculate. Therefore, a modified version of ICSI was developed in which either the isolated nuclei (ROSNI) or whole round spermatids (ROSI) as well as elongated spermatids (ELSI) obtained from ejaculate or from testicular biopsy samples, were injected directly into the oocyte (for details, see Tesarik and Mendoza, 1996) . Even though pregnancies and live births were achieved in a few reports with ejaculated round spermatids (Tesarik et al., 1995) and testicular elongated spermatids (Fishel et al., 1995; Vanderzwalmen et al., 1995) , implantation rates especially after ROSI (Vanderzwalmen et al., 1997) or ROSNI (Yamanaka et al., 1997) with testicular round spermatids were extremely low. The use of spermatids in humans has met with considerable debate regarding their suitability (Butler, 1995) since these techniques have not been extensively tested in appropriate animal models. Many investigators suggest that this procedure should be further evaluated in animal models with a similar spectrum of testicular abnormalities in order to observe possible deleterious effects on offspring as well as differences between round or elongated spermatids and mature spermatozoa.
In the mouse, fusion of oocytes and round spermatids obtained from the testes of fertile males proved successful in generating embryos, a few of which were able to develop to term (Ogura et al., 1994; Kimura and Yanagimachi, 1995) . Interestingly, fertilization rates and numbers of live offspring obtained with round spermatids were considerably lower in comparison with experiments performed with testicular spermatozoa. Similarly, ROSNI in rabbits resulted in fullterm embryo development (Sofikitis et al., 1994) . In humans however, all ROSNI pregnancies reported to date have terminated by spontaneous abortion (Hannay, 1995) . In humans, procedures such as ROSNI, ROSI, and ELSI are used for patients with spermatogenic arrest, and therefore the results are not comparable to the animal studies in which normal fertile males were used. Thus, the differences in pregnancy and live birth rates between animal models and human samples may reflect abnormalities caused by disturbed spermatogenesis. This hypothesis is further supported by the recent findings of Vanderzwalmen et al. (1997) and Amer et al. (1997) who reported an inverse correlation between ROSI fertilization and pregnancy rates, and severity of spermatogenesis failure.
Recently, we have demonstrated that spermatozoa DNA fragmentation occurs more frequently in samples with poor quality spermatozoa such as samples used for ICSI (Lopes et al., 1998a) . Similar observations were made by Hughes et al. (1996) when poor quality spermatozoa removed from the seminal fluid were exposed to oxidative agents. Furthermore, DNA sperm fragmentation is negatively correlated with fertilization rates after ICSI. From these findings, we speculate that round spermatids from azoospermic males may also demonstrate increased susceptibility to DNA damage due to their spermatogenic arrest status. Spermatogenic arrest, which may result in abnormal DNA packaging, may contribute to the failure to fertilize or support full term embryo development. This hypothesis is currently being explored in humans by Tesarik et al. (1998) . Several genetically manipulated mouse models of male infertility have been described in the literature during the past 5 years (for review, see Elliott and Cooke, 1997) . We have recently disrupted the murine protein phosphatase 1cg (Pp1g) gene (Varmuza et al., 1999) . This gene encodes the catalytic subunit of type1 serine/threonine protein phosphatase. Alternative splicing of the Pp1cg RNA generates a testis-specific isoform, Pp1cg 2, whose protein product is abundantly expressed in spermatocytes and spermatids (Shima et al., 1993; Chun et al., 1994) . The only obvious phenotype in mice homozygous for the mutant allele of Pp1cg is male sterility due to a failure in spermiogenesis beginning at the round spermatid stage. The defect is accompanied by a 10-fold increase in the rate of cell death of germ cells in various stages of spermiogenesis (Varmuza et al., 1999) .
A fundamental question arises from the studies described above, and that is whether the elevated rate of DNA fragmentation observed in infertile men reflects the procedures used to retrieve gametes from these patients, or the underlying pathology leading to infertility. In order to address this question in a controlled experiment, we made use of the infertile Pp1cg mutant mice and their wild-type and heterozygous littermates. We investigated the rate of DNA fragmentation in both epididymal and testicular spermatozoa and spermatids in the three types of mice, and found that the underlying pathology, and not the retrieval procedure, is responsible for most of the DNA fragmentation in both spermatozoa and spermatids in infertile males. In addition, we assessed the effectiveness of antioxidant additions to the retrieval media on reducing DNA fragmentation, and found that some but not all of the fragmentation in testicular biopsy material could be reduced by antioxidants.
Materials and methods

Epididymal biopsies
Genotyping of mice bearing a targeted mutation of the Pp1cg gene is described elsewhere (Varmuza et al., 1999) . Sexually mature male progeny (n ϭ 83) aged 8-25 weeks were killed and caudae epididymides were excised into 1 ml of modified T6 medium (125 mM NaCl, 2.6 mM KCl, 0.5 mM MgCl 2 , 0.4 mM NaH 2 PO 4 , 5.5 mM glucose, 23 mM Na lactate, 25 mM NaHCO 3 , 0.171 mM CaCl 2 , 0.2% BSA). Using dissection needles, cells stored in the cauda were forced out into the medium. Cell number and motility was determined 324 in a small aliquot from each sample using a haemocytometer. Standard haemocytes are constructed such that the coverslip is raised above the slide by exactly 0.1 mm. One half volume aliquots of samples from wild-type (ϩ/ϩ; n ϭ 15) and heterozygous (ϩ/-; n ϭ 42) males, and all of the sample from mutant (-/-; n ϭ 25) males were centrifuged and fixed in 4% paraformaldehyde in phosphate-buffered saline (PBS) and subsequently stored at 4°C for up to 2 weeks. A small aliquot of some samples from different genotypes (n ϭ 54) was used for morphological analysis after smearing cells on slides and processing them using the Papanicolau stain procedure. The time elapsed between collection and fixation of samples was~30 min. The remaining aliquots were allowed to capacitate for an additional period of 1 h in a 37°C humidified incubator supplemented with 5% CO 2, and were subsequently fixed and stored in fixative at 4°C for up to 2 weeks. All samples from ϩ/ϩ and ϩ/-males were analysed for DNA integrity by TdT-mediated dUTP nick-end labelling (TUNEL) using fluorescence activated cell sorting (FACS), and all samples from -/-males were processed through TUNEL on slides as described below. FACS is a highly quantitative and reliable method of analysing homogeneous cell populations such as epididymal spermatozoa, in which the population size is adequately large (e.g. 10 000 cells per sample). It is not suitable for mixed populations of cells such a testicular biopsies, and could not be used for epididymal samples from Pp1cg -/-males as these contained few spermatozoa.
In a separate experimental series, spermatozoa were isolated from the epididymides of mature male mice (14-18 weeks). The cauda of the left epididymis was removed and placed in 1 ml of human tubal fluid (HTF) medium (Irvine Scientific, CA, USA) supplemented with 0.5% human serum albumin (HSA, Irvine Scientific), 10 mM reduced glutathione (Sigma, St Louis, MO, USA) and 10 µM hypotaurine (Sigma) (Lopes et al, 1998b) . The right epididymis was removed and placed in 1 ml of HTF medium supplemented with 0.5% HSA. Using dissection needles, the contents of the epididymides were forced out into the medium. The released spermatozoa were fixed with 4% paraformaldehyde and cell suspensions were spread on slides and allowed to air dry. Numbers of mice used in this study were: ϩ/ϩ epididymides, n ϭ 6; ϩ/ϩ testes, n ϭ 7; ϩ/-epididymides, n ϭ 6; ϩ/-testes, n ϭ 7; -/-epididymides and testes, n ϭ 9.
Testicular biopsies
After removal of the tunica, one testis was placed in 1 ml of HTF supplemented with 0.5% HSA, 10 mM reduced glutathione and 10 mM hypotaurine. The other testis was placed in 1 ml of HTF supplemented with 0.5% HSA. The seminiferous tubules were dissected using 21-gauge needles and cells were released into the medium using forceps. Cell suspensions were centrifuged, medium was removed, and cell pellets were overlaid with paraformaldehyde. At this point samples were stored at 4°C for up to 2 weeks. Prior to performing TUNEL, cells were smeared on a slide and allowed to air dry.
Human testicular biopsies
A total of 11 samples were collected from seven patients undergoing testicular biopsy at a tertiary care fertility clinic. Written consent for use of the remaining sample for research was obtained from patients according to guidelines established for research on human subjects by the University of Toronto.
Seminiferous tubules were biopsied from the testes and were dissected using 21 gauge needles in mHTF supplemented with 0.5% HSA (Irvine Scientific) The tubules were dissected longitudinally and 'squeezed' with sterile microscope slides and sterile fire polished Pasteur pipettes until the medium was flocculent with cells. A small aliquot of this suspension was placed onto a microscope slide and assessed under phase contrast for the presence of testicular spermatozoa or round spermatids, in cases where very few spermatozoa were found. If testicular spermatozoa were found, these were assessed for concentration, motility and morphology using World Health Organization criteria (WHO, 1992) . If only round cells were present, a differential stain was used (testsimplet; Meditech, Montreal, Quebec, Canada) to confirm the presence of round spermatids. Spermatids were identified by a high nuclear to cytoplasm ratio, an acrosomal granule, which appears clear on phase contrast, and cell size relatively equal to or smaller than red blood cells present in the sample. Larger spermatogenic cells were also identified, such as Sertoli cells with a prominent nucleolus, and spermatocytes. Sertoli cell complexes were also identified.
The mixture of tissue and medium was drawn up into a Pasteur pipette and transferred into a polystyrene Falcon conical centrifuge test tube and vortexed. If the specimen contained spermatozoa, a percoll gradient (45-90%; 400 g for 30 min) was used at this point to remove larger cells before injection. The samples containing primarily spermatids were centrifuged at 400 g for 5 min prior to isolation for injection. Of this mixture,~2-3 µl was placed into several 5 µl droplets of mHTF/0.5% HSA under oil in the ICSI dish for preisolation. Spermatids were isolated from Sertoli cell complexes using a large bevelled needle with no spike (15 µm to prevent clogging of needle in very flocculent media). The spermatids were gently removed from these complexes and visually confirmed independently, first with Hoffman optics and then using phase contrast. Under Hoffman optics the criteria used was previously described (Tesarik and Mendoza, 1996) -picnotic clear looking eccentric nucleus with a darker acrosomal granule. Size was measured relative to nearby red blood cells to distinguish round spermatids from other (larger) cells such as Sertoli cells and the occasional spermatocyte. The smallest cells with a visible granule were teased from the cell mass and stored in medium until injection. Freestanding spermatids were rarely used for injection. Preisolated spermatids were then picked up using a smaller injection needle (6 µm), and moved to a droplet of 10% plyvinylpyrrolidone (PVP)/mHTF/0.5% HSA. Only spermatids that became more pliable at this step were used. The spermatids were then injected into metaphase II oocytes with one modification: when the spermatid was deposited into the cytoplasm it was re-aspirated with a small amount of cytoplasm to allow envelopment of the spermatid with cytoplasm. It is thought that this may help to activate the oocyte, although this is not yet certain.
Remaining tissue was cryopreserved using sperm maintenance media (Irvine Scientific) and concentrated sample (2:1). A small piece was also fixed with paraformaldehyde and spread onto slides as described above. The average number of oocytes injected per patient was 11.2; cleavage rates were 70% and the damage rate was 11% per injected oocyte.
TUNEL assay DNA fragmentation in the germ cells was measured using a modification of the TUNEL method. The experiments with DNA fragmentation in mature spermatozoa obtained from ϩ/ϩ and ϩ/-murine epididymides were performed as described in Sun et al. (1997) and 10 000 spermatozoa were sorted by FACS analysis. All assays of round spermatids were performed on cells mounted to slides as described in Jurisicova et al (1996) . Briefly, cells were permeabilized with Triton X-100, and a buffer containing TdT enzyme (Pharmacia) and biotinylated dUTP (Sigma) was added to the slide and allowed to incubate at 37°C for 60 min. Following the TdT reaction, slides were washed, and detection of incorporated biotinylated nucleotides was performed with streptavidin/Texas Red conjugate (Calbiochem-Novabiochem Corporation, La Jolla, CA, USA). The samples were washed 325 and counter-stained with 4,6-diamidino-2-phenylindole (DAPI). Using a fluorescent microscope, spermatozoa or round spermatids stained with DAPI were first manually counted under UV light. Red fluorescence labelling was detected using a 640 nm filter on the same field. The number of spermatozoa/round spermatids demonstrating red fluorescence was expressed as a percent of total spermatozoa/round spermatids in the field to give an average (Ϯ SEM) DNA fragmentation rate. This assessment was performed on 5-10 fields depending on the concentration of cells per sample, covering~100-200 cells per sample per mouse. For human samples, the entire sample spread on the slide was analysed and all round spermatids were counted. Care was taken to include only mature spermatozoa (if found), elongated or round spermatids in the quantitative analysis, and to exclude other cell types, based on the morphology of nuclear staining and morphology of the cells under light microscopy. DAPI staining of round spermatids reveals distinct round nuclei with pale chromatin, partially condensed in the periphery and brightly stained single nucleoli.
Statistical analysis
The Wilcoxon Signed Rank Test or the Mann-Whitney Rank Sum Test were used to determine if a statistically significant difference existed between each group tested using the SigmaStat statistical package (Version 1.0; Jandell Scientific, CA, USA). P Ͻ 0.05 was considered to be significant.
Results
Analysis of the cell population obtained from cauda epididymis in mice with a targeted disruption of the Pp1cg gene
We have previously established that both wild-type (ϩ/ϩ) and heterozygous (ϩ/-) males in our Pp1cg mutant colony are fertile and are able to sire normal offspring (Varmuza et al., 1999) . Sperm samples obtained from their epididymides showed no significant difference either in sperm count, motility or morphology. However, homozygous mutant males (-/-) are sterile, and display spermatogenic arrest. Their epididymides contained few cells and these were mainly arrested round spermatids (73% of all cells retrieved). A few mutant males possessed the occasional elongating or condensing spermatids (6%), and non-motile spermatozoa with normal (9%) or abnormal (12%) morphology (Table I) .
Analysis of DNA integrity of freshly harvested sperm samples from both ϩ/ϩ and ϩ/-males showed low levels of DNA fragmentation (Table I) . These levels doubled after capacitation, but there was no significant difference between the two genotypes as measured by a Wilcoxon signed rank test. In contrast, -/-males displayed a high proportion (40.6 Ϯ 4.06%) of round spermatids with fragmented DNA, indicating an increased rate of DNA damage in these cell types. Of the small number of spermatozoa observed in a second set of mice, a similar high proportion (34.3 Ϯ 9.9%) displayed evidence of DNA fragmentation that is significantly different from the level of fragmentation in wild-type epididymal spermatozoa (P Ͻ 0.05) ( Table II) .
Effect of antioxidants on sperm DNA fragmentation
In the section above, we observed an increased rate of epididymal sperm DNA fragmentation following capacitation. n ϭ 7 n ϭ 7 n ϭ 9 Testicular 3.9 Ϯ 1.5 b 0.3 Ϯ 0.3 5.4 Ϯ 3.8 1.1 Ϯ 1.1 27.4 Ϯ 6.8 b,c 11.9 Ϯ 3.8 c round spermatids n ϭ 7 n ϭ 7 n ϭ 9 HTF ϭ human tubal fluid; AO ϭ antioxidants. Differences between samples with similar symbols are statistically significant; a P Ͻ 0.05, b P Ͻ 0.01, c P ϭ 0.02. All other pair-wise comparisons were not statistically significant. Differences between genotypes were assessed by Mann-Whitney Rank Sum test. Differences between media (Ϯ antioxidants) were assessed by Wilcoxon Rank Sum test.
To assess the effect of the Pp1cg mutation on DNA fragmentation in mice, we examined epididymal and testicular spermatozoa that had been retrieved under similar conditions to those performed in humans, with the exception that a vortexing step was omitted. In addition, we tested the effect of antioxidants on DNA fragmentation in these samples, since we have previously shown inhibition of DNA fragmentation by taurine and glutathione in ejaculated spermatozoa exposed to reactive oxygen species (Lopes et al., 1998b) . The rates of DNA fragmentation in epididymal spermatozoa collected under these conditions from ϩ/ϩ and ϩ/-males were comparable and low (Table II) . Supplementation of medium with antioxidants had no significant positive effect on epididymal sperm DNA fragmentation in either ϩ/ϩ males or ϩ/-males. Of the few epididymal spermatozoa found in -/-mice, antioxidants similarly had no significant effect on DNA fragmentation, although this observation may be confounded by the small sample size. The spermatozoa obtained from testes exhibited slightly higher rates of DNA damage than epidydimal spermatozoa, since an average 4.1 Ϯ 0.7% in ϩ/ϩ males and 4.2 Ϯ 2.0% in ϩ/-males labelled positive for TUNEL. Antioxidants did not significantly alter the frequency of testicular spermatozoa DNA fragmentation as measured by a Wilcoxon Signed Rank test. The apparent trend towards positive antioxidant effect was not statistically significant. However, the elevated incidence of 326 DNA fragmentation in testicular spermatozoa obtained from mutant males was statistically different from that of wild-type males (P Ͻ 0.01). In addition, treatment of mutant testicular spermatozoa with antioxidants was effective at reducing the rate of DNA fragmentation by~50% (P ϭ 0.02; Table II ).
DNA fragmentation in round spermatids from Pp1cg -/-testes and effect of antioxidants
In our initial experiments, it was unclear whether the high rate of DNA fragmentation in round spermatids isolated from mutant epididymides was a consequence of the mutation, or of the isolation procedure, since normal ϩ/ϩ and ϩ/-males did not shed round spermatids into the epididymis. In order to determine whether round spermatids from mutant males are more susceptible to DNA fragmentation, we compared spermatids recovered from biopsies of mutant, wild-type or heterozygous testes. It should be pointed out that the mouse testicular biopsies were not vortexed during preparation, as was the case for the human samples used for ICSI. Round spermatids from normal males displayed a low rate of DNA fragmentation in contrast to round spermatids obtained from testes of mutant males. This suggests that round spermatids from mutant males with a defect in spermiogenesis have a predisposition to DNA fragmentation.
While epididymal spermatids displayed a very high rate of DNA fragmentation after retrieval (Figure 1) , the incidence of TUNEL positive round spermatids in embedded epididymal sections was low (data not shown). Similarly, while testicular sections revealed an elevated level of DNA fragmentation in several cell types in mutant testes (Figure 2 ), the rate of DNA fragmentation in cells retrieved from mutant testes was much higher (Table II) . This suggested that at least a portion of the DNA fragmentation was a consequence of the culture conditions under which the epididymal or testicular cells were recovered. We therefore tested the efficacy of antioxidants as a protective agent against DNA fragmentation of testicular round spermatids. Inclusion of antioxidants had little effect on the rate of DNA fragmentation in testicular round spermatids from wild-type or heterozygous males. However, round spermatids from mutant males displayed significantly reduced levels of DNA fragmentation (P ϭ 0.02) when antioxidants were included in the culture media (Table II) .
DNA fragmentation in round spermatids in patients with non-obstructive azoospermia
A total of 11 testicular biopsy samples obtained from seven patients with non-obstructive azoospermia undergoing the ICSI/ELSI/ROSI procedure were analysed using DAPI/ TUNEL. We concentrated on assessing the DNA integrity of round spermatids even if a few maturing spermatozoa were found. The observed mean level of DNA fragmentation in round spermatids was 56.3 Ϯ 2.7% with a range of 18-78%. Our sample size is too small to do any proper statistical analysis, but there was no obvious connection between the presence of mature spermatozoa and the rate of DNA fragmentation in round spermatids. All of the results are summarized in Table III . Interestingly, the patient that had the lowest rates of round spermatid DNA fragmentation (18%) and no mature spermatozoa, was the only one who sired an embryo that upon transfer resulted in a clinical pregnancy. Unfortunately this pregnancy ended by spontaneous miscarriage during the first trimester.
Discussion
There are several known causes of spermatogenic arrest in humans including undescended testes, Kleinfelter's syndrome, and microdeletions of the Y chromosome (Chandley and Cooke, 1994) . These represent only a subset of the diagnosed cases of non-obstructive azoospermia; the rest are due to unknown causes. Considerably more genetic data in the mouse indicates that a wide range of mutations may affect male fertility without compromising either female fertility or general viability (Elliot and Cooke, 1997). These mutations, many of them targeted in vitro, e.g. the Pp1cg mutation discussed here, should provide a good pool of candidate defects in human male factor infertility. In this study we attempted to mimic the clinical procedures, with respect to germ cell source and media, in a murine model of non-obstructive azoospermia, the Pp1cg targeted mutation. We observed that both epididymal and testicular spermatozoa from mutant, but not from normal, males exhibit a high rate of DNA fragmentation. In addition, round spermatids recovered from the testes of mutant mice and azoospermic patients displayed high rates of DNA fragmentation, while similar cells from normal mice did not. Our data nicely complement those reported recently by Tesarik et al. (1998) , who reported similar rates of round spermatid DNA fragmentation in patients with incomplete spermiogenesis arrest. These findings clearly implicate spermiogenic failure as a strong correlate with fragmented DNA in germ cells from azoospermic males.
During spermiogenesis, histones in the round spermatid stage are replaced by protamines in the elongated spermatid (Balhorn, 1982) . This transition allows for sperm chromatin to be packaged into a condensed volume thereby making mature sperm DNA highly resistant to physical or chemical denaturation. Our previous analysis of Pp1cg -/-testes suggested that round spermatids fail to undergo the normal process of histone/protamine exchange, since we observed that DNA of mutant elongated spermatids found in seminiferous tubules remain associated with histones, and crude protein extracts from mutant testes were severely depleted of protamines (Varmuza et al., 1999) . Similarly, samples obtained from human patients with spermiogenic arrest show lack of histone/ protamine exchange (Silvestroni et al., 1976) . DNA packaging anomalies involving histone/protamine exchange may result in problems with chromatin remodelling, abnormal DNA 328 methylation, and increased sensitivity of DNA to damage (Bianchi et al., 1993) .
Many different genetic defects could result in similar phenotypes. For example, the CREM targeted mutation, which results in failure to express several spermatogenic genes including protamines and transitions proteins (Blendy et al., 1996; Nantel et al., 1996) , produces a similar spectrum of histological defects to the Pp1cg mutation, suggesting that both genes operate in the same cytodifferentiation pathway. Thus, defects in many different genes could result in azoospermia in which round spermatids have fragile DNA.
At present, the reason for sperm DNA fragmentation is unclear. Several groups, including ours, proposed that the presence of endogenous nicks in ejaculated human spermatozoa may be due to apoptosis as observed in somatic cells (Gorczyka et al., 1993; Sun et al., 1997) . In this context, apoptosis may lead to functional elimination of possibly defective gametes from the genetic pool. It was reported that testicular biopsies obtained from patients with maturation arrest and hypospermiogenesis contained higher levels of apoptotic cells than samples of patients with normal spermiogenesis (Lim et al., 1997) .
In our study, comparable rates of DNA fragmentation were observed in azoospermic human patients and mice homozygous for the mutant Pp1cg allele. Phenotypic analysis of this mutation revealed that haploid spermatids, particularly elongating and condensing spermatids, are depleted, retain histones beyond the normal stage for their removal, and express lower levels of some transition proteins and protamines (Varmuza et al., 1997) . These observations suggest that the chromatin in mutant spermatids is not properly remodelled, and may therefore be more fragile.
Although programmed cell death may explain some of the DNA fragmentation seen in mutant round spermatids, our results indicate that a significant proportion of DNA damage might also be due to the in-vitro preparation process. A lengthy period of time is passed in the laboratory between the isolation of spermatids from testicular tissue to the time of injection. During this time, both mature spermatozoa and spermatids were reported to generate reactive oxygen species (de Lamirande and Gagnon, 1993; Fisher and Aitken, 1997) which are one of the possible triggers of DNA damage.
Antioxidant supplementation had been proposed in other studies to improve sperm quality (Baker et al., 1996) and inhibit DNA fragmentation induced by X-rays (Hughes et al., 1998) . Moreover, testes contain high levels of glutathione, which may protect cells within the seminiferous epithelium against any kind of damage by reactive oxygen species (ROS) (Agrawal and Vahna-Perttulla, 1988) . Thus, the inclusion of glutathione in culture medium during testicular biopsy may mimic a more natural environment for germ cells. Pretreatment of spermatozoa with free radical scavengers has been shown to protect sperm DNA from damage by ROS produced during the sperm preparation process (Lopes et al., 1998b) . Our findings indicate that mutant round spermatids are much more susceptible to oxidative stress than similar cells from normal males, as revealed by the ability of antioxidants to reduce DNA fragmentation of mutant, but not normal, spermatids. Therefore, while it may be beneficial to supplement the medium used for isolation and preparation of human testicular samples for ICSI, ELSI or ROSNI with antioxidants, the long-term consequences of using abnormal spermatids on fetal development have not been evaluated.
Extensive documentation of the use of ICSI with testicular spermatozoa from azoospermic males has revealed that fertilization rates are slightly reduced in cases involving partial germ cell aplasia or maturation arrest, but embryo development and implantation are comparable with ICSI using ejaculated spermatozoa (for review, see Elliott and Cooke, 1997) . The data are less well documented for ROSI, however, and the success in achieving pregnancy and term delivery appears to be dramatically reduced, in comparison with ICSI. As almost nothing is known about the ability of immature spermatids to support full term embryonic development, this technique should be viewed as experimental. Use of appropriate animal models of non-obstructive azoospermia, such as the Pp1cg mutation may provide us with tools to address these issues.
